CHU Hôtel Dieu

Nantes, Cedex 01 44093

0 studies enrolling now · 1 studies all time

What they study most

T-cell Non-Hodgkin's Lymphoma

Studies at this site

• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma — Stopped early